N. Soyer Et Al. , "Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.," Turkish journal of medical sciences , vol.51, no.3, pp.1033-1042, 2021
Soyer, N. Et Al. 2021. Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.. Turkish journal of medical sciences , vol.51, no.3 , 1033-1042.
Soyer, N., Ali, R., Turgut, M., Haznedaroğlu, İ. C., Yılmaz, F., Aydoğdu, İ., ... Pir, A.(2021). Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.. Turkish journal of medical sciences , vol.51, no.3, 1033-1042.
Soyer, Nur Et Al. "Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.," Turkish journal of medical sciences , vol.51, no.3, 1033-1042, 2021
Soyer, Nur Et Al. "Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.." Turkish journal of medical sciences , vol.51, no.3, pp.1033-1042, 2021
Soyer, N. Et Al. (2021) . "Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.." Turkish journal of medical sciences , vol.51, no.3, pp.1033-1042.
@article{article, author={Nur Soyer Et Al. }, title={Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.}, journal={Turkish journal of medical sciences}, year=2021, pages={1033-1042} }